title: Solitary solid renal mass: can we predict malignancy?
abstract: What's known on the subject? and What does the study add? It is known that the majority (80%) of solid renal masses are malignant. Most of the literature suggests that smaller tumour size is associated with a higher incidence of benign disease. We have confirmed that decreased tumour size is associated with benign disease, particularly for lesions <2 cm. Once radiologically apparent angiomyolipomas are excluded, the incidence of benign disease with small renal masses is lower than reported in the literature (11%). Furthermore, we have shown that small renal masses in females have a higher association with benign disease. Patient age and tumour location were not predictive of benign histology. We have also stratified our risks not only for benign disease but also for clinically indolent renal cancers to help physicians counsel patients with regard to managing these solid renal masses.
  
  
  OBJECTIVE
  • To determine the clinical predictors of benign disease in patients with solitary solid renal masses.
  
  
  METHODS
  • Pathology reports of patients who underwent radical or partial nephrectomy at two hospitals from 1998 to 2008 were reviewed. • Only patients with solitary solid unilateral renal masses were included. • Predictors of malignancy risk were assessed with univariate and multivariate logistic regression analysis.
  
  
  RESULTS
  • A total of 592 patients with a mean (sd) age of 60 (13) years were included, 38% of whom were women. Radical and partial nephrectomy was performed in 66% and 34% of patients, respectively. • Renal masses were equally distributed on the right and left sides (49% vs 51%, P= 0.84). Masses were more commonly located in the upper and lower poles than in the mid pole (40.8% vs 38.7% vs 20.5%, respectively). • The mean tumour size was larger in patients who underwent radical compared with partial nephrectomy (6.8 cm vs 2.9 cm, P < 0.001). The rate of benign disease in our overall population was 9.5%. • On univariate and multivariate analysis, only a renal mass size <2 cm and female gender were predictive of benign disease. On further analysis the magnitude of this effect was found to be additive.
  
  
  CONCLUSIONS
  • Renal masses <2 cm and female gender were associated with a higher probability of benign disease. • Patient age and tumour location were not predictive of benign disease.
authors.affiliation: Divisions of Urology, McGill University Health Centre, Montreal, QC, Canada.
authors.forename: Philippe
authors.initials: P
authors.lastname: Violette
authors.forename: Samuel
authors.initials: S
authors.lastname: Abourbih
authors.forename: Konrad M
authors.initials: KM
authors.lastname: Szymanski
authors.forename: Simon
authors.initials: S
authors.lastname: Tanguay
authors.forename: Armen
authors.initials: A
authors.lastname: Aprikian
authors.forename: Keith
authors.initials: K
authors.lastname: Matthews
authors.forename: Fadi
authors.initials: F
authors.lastname: Brimo
authors.forename: Wassim
authors.initials: W
authors.lastname: Kassouf
mesh_terms: D018207:Angiomyolipoma / Q000175:diagnosis* / Q000453:epidemiology; D002292:Carcinoma, Renal Cell / Q000175:diagnosis* / Q000453:epidemiology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D015994:Incidence; D007674:Kidney Diseases / Q000175:diagnosis* / Q000453:epidemiology; D007680:Kidney Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011792:Quebec / Q000453:epidemiology; D012189:Retrospective Studies; D012737:Sex Factors